Selected Press Releases
Announcement, February 12, 2013
Announcement, December 12, 2012
Announcement, March 12, 2012
Newsletter, September 26, 2011
Press Release, May 17, 2011
Press Release, May 16, 2011
Allan Goldberg serves as a member of SuperGen's Board of Directors and
Chairman of its Scientific Advisory Board.
Press Release, April 6, 2011
Allan Goldberg is a co-founder of ZyStor Therapeutics and a co-inventor of its core technology, additionally he served on ZyStor's Board of Directors.
Press Release, August 17, 2010
Partners of The Channel Group appointed to Board of Directors and Management of Phage Pharmaceuticals.
Press Release, May 24, 2010
Press Release, December 3, 2009
Press Release, September 17, 2008
The Channel Group partners with Pacific Channel Limited and New Zealand Venture Investment Fund to invest NZ$8-12 million into new biotech ventures
Press Release, June 5, 2008
Presentations by Robert Beckman and Allan Goldberg, Ph.D. at an Ernst & Young
Seminar in Auckland, New Zealand.
Meeting Announcement, April 14, 2008
Robert Beckman served on the Executive Committee of E-Z-EM, Inc.
Press Release, October 30, 2007
Living Cell Technologies Enhances U.S. Capabilities: Appoints The Channel Group to Lead Commercial and Capital Markets Initiatives
Press Release, July 2, 2007
Blood test for stroke under development by The Channel Group's recently formed company, Lesanne Life Sciences
Press Release, May 29, 2007
Presentation Poster, April 26, 2007
Philip Sussman established multiple pharmaceutical strategic alliances.
BioCentury, March 22, 2004
Article by Philip Sussman based on his presentation at the Technology Development Workshop in Pharmacogenomics at the Drug Discovery Technology Conference.
Current Drug Discovery, February 2004